Cargando…
Can rodent models elucidate the pathomechanisms of genetic epilepsy?
Autosomal dominant sleep‐related hypermotor epilepsy (ADSHE; previously autosomal dominant nocturnal frontal lobe epilepsy, ADNFLE), originally reported in 1994, was the first distinct genetic epilepsy shown to be caused by CHNRA4 mutation. In the past two decades, we have identified several functio...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291625/ https://www.ncbi.nlm.nih.gov/pubmed/33689168 http://dx.doi.org/10.1111/bph.15443 |
_version_ | 1784749180105785344 |
---|---|
author | Okada, Motohiro |
author_facet | Okada, Motohiro |
author_sort | Okada, Motohiro |
collection | PubMed |
description | Autosomal dominant sleep‐related hypermotor epilepsy (ADSHE; previously autosomal dominant nocturnal frontal lobe epilepsy, ADNFLE), originally reported in 1994, was the first distinct genetic epilepsy shown to be caused by CHNRA4 mutation. In the past two decades, we have identified several functional abnormalities of mutant ion channels and their associated transmissions using several experiments involving single‐cell and genetic animal (rodent) models. Currently, epileptologists understand that functional abnormalities underlying epileptogenesis/ictogenesis in humans and rodents are more complicated than previously believed and that the function of mutant molecules alone cannot contribute to the development of epileptogenesis/ictogenesis but play important roles in the development of epileptogenesis/ictogenesis through formation of abnormalities in various other transmission systems before epilepsy onset. Based on our recent findings using genetic rat ADSHE models, harbouring Chrna4 mutant, corresponding to human S284L‐mutant CRHNA4, this review proposes a hypothesis associated with tripartite synaptic transmission in ADSHE pathomechanisms induced by mutant ACh receptors. LINKED ARTICLES: This article is part of a themed issue on Building Bridges in Neuropharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.8/issuetoc |
format | Online Article Text |
id | pubmed-9291625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92916252022-07-20 Can rodent models elucidate the pathomechanisms of genetic epilepsy? Okada, Motohiro Br J Pharmacol Building Bridges in Neuropharmacology ‐ Themed Issue Reviews Autosomal dominant sleep‐related hypermotor epilepsy (ADSHE; previously autosomal dominant nocturnal frontal lobe epilepsy, ADNFLE), originally reported in 1994, was the first distinct genetic epilepsy shown to be caused by CHNRA4 mutation. In the past two decades, we have identified several functional abnormalities of mutant ion channels and their associated transmissions using several experiments involving single‐cell and genetic animal (rodent) models. Currently, epileptologists understand that functional abnormalities underlying epileptogenesis/ictogenesis in humans and rodents are more complicated than previously believed and that the function of mutant molecules alone cannot contribute to the development of epileptogenesis/ictogenesis but play important roles in the development of epileptogenesis/ictogenesis through formation of abnormalities in various other transmission systems before epilepsy onset. Based on our recent findings using genetic rat ADSHE models, harbouring Chrna4 mutant, corresponding to human S284L‐mutant CRHNA4, this review proposes a hypothesis associated with tripartite synaptic transmission in ADSHE pathomechanisms induced by mutant ACh receptors. LINKED ARTICLES: This article is part of a themed issue on Building Bridges in Neuropharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.8/issuetoc John Wiley and Sons Inc. 2021-05-12 2022-04 /pmc/articles/PMC9291625/ /pubmed/33689168 http://dx.doi.org/10.1111/bph.15443 Text en © 2021 The Author. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Building Bridges in Neuropharmacology ‐ Themed Issue Reviews Okada, Motohiro Can rodent models elucidate the pathomechanisms of genetic epilepsy? |
title | Can rodent models elucidate the pathomechanisms of genetic epilepsy? |
title_full | Can rodent models elucidate the pathomechanisms of genetic epilepsy? |
title_fullStr | Can rodent models elucidate the pathomechanisms of genetic epilepsy? |
title_full_unstemmed | Can rodent models elucidate the pathomechanisms of genetic epilepsy? |
title_short | Can rodent models elucidate the pathomechanisms of genetic epilepsy? |
title_sort | can rodent models elucidate the pathomechanisms of genetic epilepsy? |
topic | Building Bridges in Neuropharmacology ‐ Themed Issue Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291625/ https://www.ncbi.nlm.nih.gov/pubmed/33689168 http://dx.doi.org/10.1111/bph.15443 |
work_keys_str_mv | AT okadamotohiro canrodentmodelselucidatethepathomechanismsofgeneticepilepsy |